Oliver G Ottmann

The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines

O. Ottmann, Patricia Mambou Gwanmesia, Annette Romanski, 2009, BMC Cancer.

Transcriptional Profiling of Human Hematopoiesis During In Vitro Lineage‐Specific Differentiation

S. de Vos, W. Hofmann, O. Ottmann, 2005, Stem cells.

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Sante Tura, Thomas Fischer, Alois Gratwohl, 2002, Blood.

CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.

A. Sewell, G. Dolton, M. Legut, 2018, Blood.

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

David Elashoff, H Phillip Koeffler, S. de Vos, 2002, The Lancet.

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.

Randy Allred, Hubert Serve, Wolfgang E Berdel, 2005, Blood.